Nicola Marchi mainly focuses on Blood–brain barrier, Epilepsy, Inflammation, Central nervous system and Pathology. Nicola Marchi performs multidisciplinary study on Blood–brain barrier and Cell growth in her works. She focuses mostly in the field of Epilepsy, narrowing it down to topics relating to Pharmacology and, in certain cases, Human brain, Anticonvulsant, Phenytoin and Status epilepticus.
Her Inflammation research is multidisciplinary, relying on both Neuroscience, Immune system and Cell biology. Her Central nervous system research is multidisciplinary, incorporating elements of Brain damage, Anesthesia and Central nervous system disease. Her research integrates issues of Cognition and Traumatic brain injury in her study of Pathology.
Blood–brain barrier, Neuroscience, Epilepsy, Pathology and Pharmacology are her primary areas of study. The study incorporates disciplines such as Inflammation, Endothelium and Traumatic brain injury in addition to Blood–brain barrier. Her biological study deals with issues like Seizure Disorders, which deal with fields such as Bioinformatics.
Her Pilocarpine study in the realm of Epilepsy interacts with subjects such as P-glycoprotein. Nicola Marchi interconnects Status epilepticus and Microglia in the investigation of issues within Pathology. As part of the same scientific family, Nicola Marchi usually focuses on Pharmacology, concentrating on Carbamazepine and intersecting with Pharmacokinetics.
The scientist’s investigation covers issues in Internal medicine, Blood–brain barrier, Neuroscience, Epilepsy and Endocrinology. Her Internal medicine study incorporates themes from Mesenchymal stem cell and Cardiology. Her studies deal with areas such as Immunohistochemistry, Inflammation, CYP3A4, Cell biology and Traumatic brain injury as well as Blood–brain barrier.
She has included themes like Stem cell, Immune system, Disease and Cerebral edema in her Inflammation study. In Neuroscience, Nicola Marchi works on issues like Metabotropic glutamate receptor, which are connected to Pentylenetetrazol. Her specific area of interest is Epilepsy, where she studies Epileptogenesis.
Her primary areas of investigation include Neuroscience, Epilepsy, Epileptogenesis, Agonist and Hippocampal sclerosis. In general Neuroscience, her work in Central nervous system and Meninges is often linked to Crosstalk linking many areas of study. Her studies deal with areas such as Immune system, Immunology, Endogeny and Glucocorticoid receptor as well as Epilepsy.
Her Epileptogenesis research includes elements of Pathological, Pathology and Status epilepticus. Her research in Vasodilation intersects with topics in Blood–brain barrier and Traumatic brain injury. Nicola Marchi combines subjects such as NMDA receptor, Inflammation, Oxygenation, Pathophysiology and Vasoconstriction with her study of Blood–brain barrier.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Seizure-Promoting Effect of Blood–Brain Barrier Disruption
Nicola Marchi;Lilyana Angelov;Thomas Masaryk;Vincent Fazio.
Epilepsia (2007)
Serum S100β: A Noninvasive Marker of Blood-Brain Barrier Function and Brain Lesions
Andrew A. Kanner;Andrew A. Kanner;Nicola Marchi;Vincent Fazio;Marc R. Mayberg;Marc R. Mayberg.
Cancer (2003)
Peripheral markers of brain damage and blood-brain barrier dysfunction
Nicola Marchi;Peter Rasmussen;Miranda Kapural;Vince Fazio.
Restorative Neurology and Neuroscience (2003)
The role of shear stress in Blood-Brain Barrier endothelial physiology
Luca Cucullo;Luca Cucullo;Mohammed Amir Hossain;Mohammed Amir Hossain;Vikram Puvenna;Vikram Puvenna;Nicola Marchi;Nicola Marchi.
BMC Neuroscience (2011)
Consequences of Repeated Blood-Brain Barrier Disruption in Football Players
Nicola Marchi;Jeffrey J. Bazarian;Vikram Puvenna;Mattia Janigro.
PLOS ONE (2013)
Peripheral markers of blood–brain barrier damage
Nicola Marchi;Marco Cavaglia;Vincent Fazio;Sunil Bhudia.
Clinica Chimica Acta (2004)
Antagonism of peripheral inflammation reduces the severity of status epilepticus
Nicola Marchi;Qingyuan Fan;Chaitali Ghosh;Vincent Fazio.
Neurobiology of Disease (2009)
Inhibition of the Multidrug Transporter P-Glycoprotein Improves Seizure Control in Phenytoin-treated Chronic Epileptic Rats
Erwin A. Van Vliet;Rosalinde Van Schaik;Peter M. Edelbroek;Sandra Redeker.
Epilepsia (2006)
Inflammatory pathways of seizure disorders
Nicola Marchi;Tiziana Granata;Damir Janigro.
Trends in Neurosciences (2014)
Development of a Humanized In Vitro Blood–Brain Barrier Model to Screen for Brain Penetration of Antiepileptic Drugs
Luca Cucullo;Mohammed Hossain;Ed Rapp;Toby Manders.
Epilepsia (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Case Western Reserve University
Istituto Neurologico Carlo Besta
Inserm : Institut national de la santé et de la recherche médicale
Mario Negri Institute for Pharmacological Research
Cleveland Clinic
Cleveland Clinic
University of Montpellier
Cleveland Clinic
Mario Negri Institute for Pharmacological Research
University of Montpellier
University of Nebraska–Lincoln
University of Nantes
University of Illinois at Chicago
University Medical Center Groningen
University of Guelph
Skidaway Institute of Oceanography
Novartis (Switzerland)
University of Pittsburgh
Research Center Borstel - Leibniz-Center for Medicine and Biosciences
University of Liverpool
Hokkaido Information University
University of British Columbia
University of Glasgow
University of Pisa
University of Illinois at Chicago
Inserm : Institut national de la santé et de la recherche médicale